<?xml version="1.0" encoding="UTF-8"?><!-- Converted from Majour with majour2a++ V1.5 --><!--Automatically converted from version 2.3 to 2.4-->

<!DOCTYPE Publisher
  PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>

   <PublisherInfo>

      <PublisherName>Springer-Verlag</PublisherName>

      <PublisherLocation>Berlin/Heidelberg</PublisherLocation>

   </PublisherInfo>

   <Journal>

      <JournalInfo JournalProductType="Legacy" NumberingStyle="Unnumbered">

         <JournalID>105</JournalID>

         <JournalPrintISSN>0017-8470</JournalPrintISSN>

         <JournalSPIN/>

         <JournalTitle>Der Hautarzt</JournalTitle>

         <JournalSubTitle>Zeitschrift für Dermatologie, Allergologie, Venerologie und verwandte Gebiete</JournalSubTitle>

         <JournalAbbreviatedTitle>Hautarzt</JournalAbbreviatedTitle>
         <JournalSubjectGroup>
            <JournalSubject Type="Primary">Legacy</JournalSubject>
         </JournalSubjectGroup>

      </JournalInfo>

      <Volume>

         <VolumeInfo VolumeType="Regular">
            <VolumeIDStart>46</VolumeIDStart>
            <VolumeIDEnd>46</VolumeIDEnd>
            <VolumeIssueCount/>
         </VolumeInfo>

         <Issue IssueType="Regular">

            <IssueInfo TocLevels="0">

               <IssueIDStart>4</IssueIDStart>

               <IssueIDEnd>4</IssueIDEnd>

               <IssueHistory>

                  <PrintDate>

                     <Year>1995</Year>

                     <Month>4</Month>

                     <Day>28</Day>

                  </PrintDate>

                  <CoverDate>

                     <Year>1995</Year>

                     <Month>4</Month>

                  </CoverDate>

               </IssueHistory>

               <IssueCopyright>

                  <CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName>

                  <CopyrightYear>1995</CopyrightYear>

               </IssueCopyright>

            </IssueInfo>

            <Article ID="Art1">

               <ArticleInfo Language="De" ArticleType="OriginalPaper" NumberingStyle="Unnumbered" ContainsESM="No" TocLevels="0">

                  <ArticleID>50460225.105</ArticleID>

                  <ArticleDOI>10.1007/s001050050244</ArticleDOI>

                  <ArticleTitle Language="De">Autoaggressionskrankheit – assoziierte MHC*-Klasse-II-Moleküle</ArticleTitle>

                  <ArticleSubTitle Language="De"/>

                  <ArticleCategory>AKTUELLER KOMMENTAR</ArticleCategory>

                  <ArticleFirstPage>225</ArticleFirstPage>

                  <ArticleLastPage>227</ArticleLastPage>

                  <ArticleCopyright>

                     <CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName>

                     <CopyrightYear>1995</CopyrightYear>

                  </ArticleCopyright>
                  <ArticleGrants>
                     <MetadataGrant Grant="OpenAccess"/>
                     <AbstractGrant Grant="OpenAccess"/>
                     <BodyPDFGrant Grant="Restricted"/>
                     <BodyHTMLGrant Grant="Restricted"/>
                     <BibliographyGrant Grant="Restricted"/>
                     <ESMGrant Grant="Restricted"/>
                  </ArticleGrants>

               </ArticleInfo>

               <ArticleHeader>

                  <AuthorGroup>

                     <Author AffiliationIDS="A1">

                        <AuthorName DisplayOrder="Western">

                           <GivenName>M.</GivenName>

                           <FamilyName>Trüeb</FamilyName>

                        </AuthorName>

                     </Author>

                     <Affiliation ID="A1">

                        <OrgName>University of Texas Southwestern Medical Center at Dallas</OrgName>

                        <OrgAddress>

                           <Street/>

                           <Postbox/>

                           <Postcode/>

                           <City/>

                           <State/>

                           <Country>XX</Country>

                        </OrgAddress>

                     </Affiliation>

                  </AuthorGroup>

                  <Abstract ID="Abs1" Language="De">

                     <Heading>Zusammenfassung</Heading>

                     <Para/>

                     <Para>

                        <Emphasis Type="Italic">Der MHC (major histocompatibility complex) umfaßt eine umfangreiche genetische Region, die außerordentlich polymorphe MHC-Moleküle kodiert. Diese sind befähigt, Proteinantigene derart zu binden, daß sie von T-Lymphozyten via T-Zell-Rezeptoren (TCR) spezifisch erkannt werden können. Diese Interaktionen zwischen den MHC-Peptid-Komplexen und TCR spielen eine wichtige Rolle in der Elaborierung des sog. T-Zell-Repertoires und der (erworbenen) Immunantwort gemeinhin. Unter den mit Autoaggressionskrankheiten assoziierten MHC-Molekülen dominieren Allele der Klasse II (e.g. HLA-DQ, HLA-DR). Die Pathophysiologie dieser inzwischen gut bekannten Assoziationen ist weitgehend unklar geblieben. Um die Bedeutung bestimmter MHC-Klasse-II-Moleküle für die Pathogenese assoziierter Autoaggressionskrankheiten zu untersuchen, wurden unlängst in vivo Modelsysteme geschaffen, in denen humane MHC-Klasse-II-Moleküle in transgenen Mäusen exprimiert werden. Es ist zu erwarten, daß diese MHC-transgenen Mäuse Einblicke in die Relevanz und Rolle implizierter MHC-Klasse-II-Moleküle in der Pathogenese spezifischer Autoaggressionskrankheiten gewähren werden.</Emphasis>

                     </Para>

                  </Abstract>

                  <Abstract ID="Abs2" Language="En">

                     <Heading>Summary</Heading>

                     <Para/>

                     <Para>The major histocompatibility complex (MHC) is a large region of highly polymorphic genes. MHC-encoded molecules bind foreign-protein antigens and form complexes that are recognized by antigen-specific T lymphocytes. Interactions between MHC-peptide complexes and T-cell receptors play a central role in the selection of the T-cell repertoire and in the elicitation of an immune response. The majority of disease associations with the MHC have been with class-II molecules. Despite the awareness of such associations, the pathophysiological role of MHC class-II molecules in conferring susceptibility to autoimmune disease is poorly understood. The recent demonstration that human class-II molecules can function as antigen-presenting molecules in vivo in a transgenic murine system paves the way to investigate the role of HLA class II molecules in regulating immune responses and disease susceptibility. These mice should be useful for studying the mechanisms by which particular human leukocyte antigen (HLA) alleles are associated with specific human-autoimmune diseases.</Para>

                  </Abstract>

                  <KeywordGroup Language="De">

                     <Keyword>Schlüsselwörter MHC Klasse II Moleküle</Keyword>

                     <Keyword>Polymorphismen</Keyword>

                     <Keyword>Koppelung</Keyword>

                     <Keyword>Autoimmunhaplotypus</Keyword>

                     <Keyword>MHC-Klasse-II-transgene Mäuse</Keyword>

                  </KeywordGroup>

                  <KeywordGroup Language="En">

                     <Keyword>Key words MHC class-II molecules</Keyword>

                     <Keyword>Polymorphisms</Keyword>

                     <Keyword>Linkage disequilibrium</Keyword>

                     <Keyword>Autoimmune haplotype</Keyword>

                     <Keyword>MHC class-II transgenic mice</Keyword>

                  </KeywordGroup>

               </ArticleHeader>

               <NoBody/>

            </Article>

         </Issue>

      </Volume>

   </Journal>

</Publisher>